Nordic Nanovector ASA - Private placement of new shares successfully placed
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA, SOUTH AFRICA, NEW ZEALAND, JAPAN OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL Nordic Nanovector ASA - Private placement of new shares successfully placed Reference is made to the stock exchange announcement by Nordic Nanovector ASA (OSE: NANOV) ("Nordic Nanovector” or the "Company"), a clinical-stage biotech company focused on CD37-targeted